Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go?

被引：4

作者：

Guapillo, Carolina ^{[1
]}

Hernandez-Pando, Rogelio ^{[1
]}

Alberto Flores-Valdez, Mario ^{[2
]}

机构：

[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Patol, Secc Patol Expt, Mexico City, DF, Mexico

[2] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Biotecnol Med & Farmaceut, Ave Normalistas 800, Guadalajara 44270, Jalisco, Mexico

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2016年 / 12卷 / 05期

关键词：

clinical trials; multiantigenic; tuberculosis; vaccines; MYCOBACTERIUM-TUBERCULOSIS; NEGATIVE ADULTS; IMMUNOGENICITY; MTB72F/AS02; ANTIGENS; HUMANS; SAFETY;

D O I：

10.1080/21645515.2015.1136760

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The idea of presenting this commentary is to bring attention to the current status of clinical tests from several multiantigen vaccine candidates based on proteins produced by means of genetic engineering and molecular biology approaches and to suggest how new emerging technologies (OMICs) and bioinformatics might benefit vaccine development for better control of tuberculosis.

引用

页码：1193 / 1195

页数：3

共 50 条

[1] Ebola virus vaccines: Where do we stand?
Pavot, Vincent
CLINICAL IMMUNOLOGY, 2016, 173 : 44 - 49
[2] Rabies vaccines: where do we stand, where are we heading?
Kaur, Manpreet
Garg, Rajni
Singh, Samer
Bhatnagar, Rakesh
EXPERT REVIEW OF VACCINES, 2015, 14 (03) : 369 - 381
[3] Where do we stand on neuroprotection? Where do we go from here?
Shoulson, I
MOVEMENT DISORDERS, 1998, 13 : 46 - 48
[4] New approaches to vaccines against tuberculosis:: where we stand and where we want to go -: Introductory remarks to the symposium
Bröker, M
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 23 (02): : 147 - 148
[5] Mucosal Vaccines: Where Do We Stand?
Kraehenbuhl, Jean-Pierre
Neutra, Marian R.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (20) : 2609 - 2628
[6] Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?
Cazzola, Mario
Page, Clive P.
Matera, Maria Gabriella
Rogliani, Paola
Hanania, Nicola A.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (02)
[7] Tuberculosis in Mozambique: Where Do We Stand?
Nguenha D.
Manhiça I.
Garcia-Basteiro A.L.
Cowan J.
Current Tropical Medicine Reports, 2018, 5 (4) : 264 - 272
[8] Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
Joshi, Gaurav
Borah, Pobitra
Thakur, Shweta
Sharma, Praveen
Mayank
Poduri, Ramarao
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 4714 - 4740
[9] Research on Frailty: Where We Stand and Where We Need to Go
Rodriguez-Manas, Leocadio
Rodriguez-Sanchez, Isabel
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2021, 22 (03) : 520 - 523
[10] Vaccines against Tuberculosis: Where Are We Now?
Srivastava, Shruti
Dey, Sajal
Mukhopadhyay, Sangita
VACCINES, 2023, 11 (05)

← 1 2 3 4 5 →